Nancy Wedel

Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid Leukemia

Eric J. Feldman, Joseph Brandwein, Richard M. Stone et al. · Journal of Clinical Oncology · 2005 · 248 citations · Full text

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

Lynn E. S̄pitler, Maguy Del Rio, Archie Khentigan et al. · PubMed · 1987 · 215 citations

Tumor Immunology, Allergy, Autoimmune Disease +15

Preliminary evaluation of recombinant amino-terminal fragment of human bactericidal/permeability-increasing protein in children with severe meningococcal sepsis

Brett P. Giroir, Peter A. Quint, Phil Barton et al. · The Lancet · 1997 · 182 citations

Recombinant Amino-terminal Fragment, Medical Microbiology, Pathology +10

Inhibition of Endotoxin-Induced Cytokine Release and Neutrophil Activation in Humans by Use of Recombinant Bactericidal/Permeability-Increasing Protein

M. A. M. Von Der Möhlen, A N Kimmings, Nancy Wedel et al. · The Journal of Infectious Diseases · 1995 · 123 citations

Neutrophil Activation, Endotoxin Levels, Immunology +18

Treatment of relapsed or refractory acute myeloid leukemia with humanized anti-CD33 monoclonal antibody HuM195

Eric J. Feldman, M Kalaycio, George J. Weiner et al. · Leukemia · 2003 · 85 citations

Hematological Malignancy, Medicine, Mixed-phenotype Acute Leukemia +7